Investor Alert

Intellia Therapeutics Inc.



After Hours

 --Quotes are delayed by 20 min

Mar 31, 2023, 7:32 p.m.





+0.73 +1.96%


Volume 28,693

Quotes are delayed by 20 min


Previous close

$ 36.02

$ 37.27


+1.25 +3.47%

Day low

Day high




52 week low

52 week high




Eliana Clark

Currently, Eliana Clark occupies the position of Senior Vice President-Technical Operations at Intellia Therapeutics, Inc.

In the past Dr. Clark was Vice President at Biogen, Inc. and Professor at Tufts University.

Dr. Clark received a doctorate and an undergraduate degree from National University of the Littoral.


Date Shares Transaction Value
01/04/2023 1,692   Disposition at $37.21 per share. 62,960
01/03/2023 231   Disposition at $34.48 per share. 7,965
07/01/2022 105   Disposition at $51.74 per share. 5,433
03/01/2022 10,527   Award at $0 per share. 0

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Aron Stein
Senior Vice President-Regulatory Affairs
Dr. Frank A. G. M. Verwiel
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.